The Telegraph features Vinehealth as an exemplar app to support patients of mature ages
With the evidence shown by the ORCHA’s research, digital health is not only for the young audiences. People aged 55 and over have reported to be willing to use health apps to self-monitor and track symptoms, to help them in post-surgery recovery, and to alert of a potential health condition. However, the same study shows that the NHS doctors do not often recommend useful health apps to patients over 55, as such audience is stereotyped to be less tech savvy.
With this knowledge on board, The Telegraph interviewed a number of people to understand their views on older patients using digital solutions to keep on top of their health.
We were very pleased to see that one of the people interviewed was Jane, one of Vinehealth’s users and patient advisors. In the interview, Jane shared her thoughts around how capable people in their 60s and 70s are in using digital apps, and how Vinehealth helped her to stay on track with her complex medication schedule. Read the full article here.
Vinehealth works with oncologists, specialist cancer nurses (CNSs) and cancer patients to provide digital tools that allow to collect rich real-world data from patients that undergo cancer treatment. The app allows cancer patients to easily track and understand symptoms, appointments and medications, and has proven to improve patients’ quality of life. The clinical tool VinehealthPRO enables care teams to see real-time PROMs data and deliver personalised patient information, leading to better clinical decision-making, remote care and greater service efficiency. By delivering personalised, scalable support, Vinehealth boosts patient engagement and gathers rich longitudinal PROMs data; optimising clinical trials, real-world studies and patient support programmes.
Click here to learn more about Vinehealth’s solutions for rich PROMs data collection, enabling real world studies and digital Patient Support Programmes (PSPs).
Or write us a message, if you have other questions.